Krebs Andreas has filed 4 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 75187 shares of Definium Therapeutics, Inc. ($DFTX) on June 12, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 12, 2025 | Definium Therapeutics, Inc. | $DFTX | Krebs Andreas | Not found | A | Stock Option (Right to Buy) | 75187 | $0.00 | 75,187.0000 | 75,368,359 | 9999.99% | 0.10% |
| June 10, 2024 | Definium Therapeutics, Inc. | $DFTX | Krebs Andreas | Not found | A | Stock Option (Right to Buy) | 16506 | $0.00 | 16,506.0000 | 0 | 9999.99% | 0.00% |
| June 21, 2023 | Definium Therapeutics, Inc. | $DFTX | Krebs Andreas | Director | A | Common Shares | 13671 | $0.00 | 15,107.0000 | 0 | 952.02% | 0.00% |
| June 21, 2023 | Definium Therapeutics, Inc. | $DFTX | Krebs Andreas | Director | A | Stock Option (Right to Buy) | 19203 | $0.00 | 29,748.0000 | 0 | 182.11% | 0.00% |